Christopher Wolfe, Merrill Lynch Private Bank CIO, and David Darst, Morgan Stanley Wealth Management senior advisor, discuss if there is a buying opportunity in biotech after today's sharp decline in the sector.
Xena: It is pitiful to see this first lady, who the corrupt press praises so much, to go,on the last days of her legacy, so HIGH in corruption and so LOW in the truth, when it comes to help the Hillary that she despises. OH.... a job in the Clintonian Net may be the reason. Everybody has to think of the future!!!!